Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,061 AUD | 0,00% | -4,69% | +38,64% |
03/04 | Acrux, TruPharma lanceren Dapsone 5% Gel in VS | MT |
29/02 | Transcript : Acrux Limited, H1 2024 Earnings Call, Feb 29, 2024 |
Vakgebied
Verkoop per activiteit
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 5 | 100,0 % | 12 | 100,0 % | +133,74% |
Verkoop per regio
AUD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Europe and Other Countries
61,1
%
| 1 | 27,8 % | 7 | 61,1 % | +412,74% |
Australia
29,3
%
| 3 | 66,3 % | 3 | 29,3 % | +3,43% |
United States
9,6
%
| 0 | 5,9 % | 1 | 9,6 % | +282,27% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Kotsanis
CEO | Chief Executive Officer | - | 03-11-14 |
Joanna Johnson
DFI | Director of Finance/CFO | - | 21-06-21 |
Chief Tech/Sci/R&D Officer | - | 15-02-15 | |
Mark Hyman
PRN | Corporate Officer/Principal | - | 01-07-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Geoff Brooke
BRD | Director/Board Member | 68 | 01-06-16 |
Ross Dobinson
FOU | Founder | 72 | 01-01-98 |
Michael Kotsanis
CEO | Chief Executive Officer | - | 03-11-14 |
Timothy Oldham
BRD | Director/Board Member | - | 01-10-13 |
Donald Brumley
BRD | Director/Board Member | - | 04-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 289 630 985 | 238 390 258 ( 82,31 %) | 0 | 82,31 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,64% | 11,74 mln. | |
+21,28% | 44,4 mld. | |
+24,60% | 23,03 mld. | |
+18,44% | 15,14 mld. | |
+12,87% | 13,12 mld. | |
+44,67% | 11,85 mld. | |
-8,33% | 6,99 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+12,22% | 5,52 mld. |